ALDOB is a prognostic biomarker and a potential immunotherapy target for clear cell renal cell carcinoma
As a prospective predictive indicator for individuals with ccRCC, reduced <i>ALDOB</i> level exhibited strong correlations with clinical characteristics, unfavorable outcomes, and immune infiltration in individuals with ccRCC.
Authors
- Dawei Liu (ORCID: https://orcid.org/0000-0003-1911-9207)
- Tao Wang (ORCID: https://orcid.org/0000-0003-0934-7580)
- Yang Luo (ORCID: https://orcid.org/0000-0002-0166-9027)
- Qing Li (ORCID: https://orcid.org/0000-0002-5938-9167)
- Lingfei Yan
- Bo Peng (ORCID: https://orcid.org/0000-0002-1915-0549)
- Xu Wu
- Dali Wu (ORCID: https://orcid.org/0000-0002-3117-7074)
- Cuilian Li
Institutions
- Third Affiliated Hospital of Southern Medical University (CN)
Publication Details
- Journal
- PeerJ
- Published
- 2025-08-18
- DOI
- https://doi.org/10.7717/peerj.19869
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Guangdong Medical Research Foundation